Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: DMRA

Galecto, Inc.

Healthcare | Biotechnology

No licensed closing price on file for DMRA. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

Galecto, Inc. (NASDAQ: DMRA) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 07:14 UTC.

Key facts

Charts

Charts are in the appInteractive charts for DMRA are available in Oxford Ledge.
Open DMRA in Oxford Ledge →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity
Source: SEC EDGAR · Filed 2026-04-01
Most recent filed transactions — April 2026:
  • 2026-04-01See RemarksStock Option (right to buy)Award1,500,000—
  • 2026-04-01See RemarksAward500,000—
  • 2026-03-25General CounselStock Option (right to buy)Award250,000—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →
For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for DMRA and 5,000+ tickers.

Create a free account — keep DMRA
For your agent
GET /api/data?ticker=DMRA

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt